|
|
Poster Abstract Session:
42. ART: Efficacy and Resistance
Thursday, October 3, 2013: 12:30 PM-2:00 PM
Room: The Moscone Center: Poster Hall C
Tracks: HIV-STD-TB
Presentations:
|
Antiretroviral Activity and Safety of Once-daily Etravirine in Treatment-naïve HIV-infected Adults
Michelle Floris-Moore, MD, MS
;
Katie Mollan, MS
;
Aimee Wilkin, MD, MPH
;
Marc Johnson, MD
;
Angela Kashuba, BScPhm, PharmD, DABCP
;
David Alain Wohl, MD
;
Kristine Patterson, MD
;
David Ragan, RN, BSN
;
Clara Zelasky, PA
;
David Currin, RN
;
Donna Pittard, RN, BSN
;
Joseph Eron, Jr., MD
|
|
Skin Rash Related to Once-daily Boosted Darunavir-Containing Regimen in HIV-infected Patients: Incidence and Associated Factor
Kuan-Yin Lin, MD
;
Chia-Jui Yang, MD
;
Mao-Song Tsai, MD
;
Szu-Min Hsieh, MD
;
Wang-Huei Sheng, MD, PhD
;
Sui-Yuan Chang, DSc
;
Chien-Ching Hung, MD, MIH, PhD
;
Shan-Chwen Chang, MD, PhD
|
CME Credits:
ACPE Credits:
ACPE Number:
Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.
|